News

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...
The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...
Overall Medicaid spending on GLP-1 drugs — before partial rebates from drug manufacturers ... expensive oral medications approved by the FDA for weight loss, as well as nutrition counseling.